{
    "root": "30b47c4b-3c4d-d6fd-e063-6294a90a5664",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Vitamin D",
    "value": "20250319",
    "ingredients": [
        {
            "name": "SOYBEAN OIL",
            "code": "241ATL177A"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "ERGOCALCIFEROL",
            "code": "VS041H42XC"
        }
    ],
    "indications": "Ergocalciferol is indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.",
    "contraindications": "THE RANGE BETWEEN THERAPEUTIC AND TOXIC DOSES IS NARROW.\n                  Vitamin D Resistant Rickets: 12,000 to 500,000 USP units daily.\n                  Hypoparathyroidism: 50,000 to 200,000 USP units daily concomitantly with calcium lactate 4 g, six times per day.\n                  DOSAGE MUST BE INDIVIDUALIZED UNDER CLOSE MEDICAL SUPERVISION.\n                  Calcium intake should be adequate. Blood calcium and phosphorous determinations must be made every 2 weeks or more frequently if necessary. X-rays of the bones should be taken every month until condition is corrected and stabilized.",
    "warningsAndPrecautions": "Each green, oval softgel is imprinted with PA140 and contains 1.25 mg (50,000 USP units vitamin D) of ergocalciferol, USP, and is available in bottles of 100 (69452-151-20) Softgels.\n                  Store at 25° C (77° F); excursions permitted to 15° - 30° C (59° - 86 ° F) [See USP Controlled Room Temperature.]\n                  Protect from light and moisture.\n                  Dispense in a tight, light-resistant container as defined in the USP.\n                  Manufactured for:\n  \nBionpharma Inc.\n  \n600 Alexander Road\n  \nPrinceton, NJ 08540, USA\n  \nRev. 12/2015",
    "adverseReactions": "Ergocalciferol is contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin D, and hypervitaminosis D."
}